The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
TUMOUR NECROSIS FACTOR ALPHA AND ITS SOLUBLE RECEPTORS PARALLEL CLINICAL DISEASE AND AUTOIMMUNE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Open accessAbstract
Cytokines are believed to play an important role in the pathogenesis of systemic lupus erythematosus (SLE). However, for tumour necrosis factor alpha (TNF-alpha) both beneficial and deleterious effects have been reported. To obtain information about the involvement of this cytokine in the pathophysiology of SLE, serum levels of TNF-alpha, the soluble forms of the 55 and 75 kDa tumour necrosis factor receptors (TNF-R55 and TNF-R75), and interleukin-6 (IL-6) were measured by ELISA in nine female patients over a period of 2 yr. Compared to healthy controls, levels of TNF-alpha (median 47 pg/ml, range < 15-222 pg/ml), TNF-R55 (median 1.9 ng/ml, range 0.8-10.8 ng/ml), TNF-R75 (median 4.7 ng/ml, range 1.5-15 ng/ml) and IL-6 (median 3.5 pg/ml, range < 3.5-52 pg/ml) were significantly elevated in SLE patients (P < 0.0001 vs controls in all cases). There were strong correlations between TNF-alpha and its soluble receptors (P < 0.0001). Moreover, TNF-alpha and both TNF-Rs strongly correlated with clinical and serological parameters of disease activity, such as the European Consensus Lupus Activity Measurement (ECLAM) score, anti-dsDNA antibodies, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and anaemia (P < 0.0001 for all comparisons). TNF-alpha and TNF-R75 also correlated with IL-6 (P < 0.0001). However, no correlation between IL-6 and ECLAM was found, and the correlation of IL-6 with anti-dsDNA was relatively weak; in contrast, IL-6 correlated strongly with CRP and ESR (P < 0.0001). Although these data do not allow us ultimately to discriminate between beneficial and deleterious effects of TNF-alpha, they nevertheless suggest a central role for the TNF system in the pathophysiology of SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Immune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
The two different receptors for tumor necrosis factor mediate distinct cellular responses.
Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C., Palladino, M. A., & Goeddel, D. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9292 · Cited by 807
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
Jacob, C. O., & McDevitt, H. O. (1988) · Nature · doi:10.1038/331356a0 · Cited by 596
Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
Linker-Israeli, M., Deans, R. J., Wallace, D. J., Prehn, J., Ozeri-Chen, T., & Klinenberg, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.117 · Cited by 549
Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., & Howard, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.305 · Cited by 532
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
Shedding of tumor necrosis factor receptors by activated human neutrophils.
Porteu, F., & Nathan, C. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.599 · Cited by 437
Cited by
Denny, M. F., Yalavarthi, S., Zhao, W., Thacker, S. G., Anderson, M., Sandy, A. R., McCune, W. J., & Kaplan, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902199 · Cited by 701
Drug-induced systemic lupus erythematosus associated with etanercept therapy
Shakoor, N., Michalska, M., Harris, C. A., & Block, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07714-0 · Cited by 458
Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity
Carmona-Rivera, C., & Kaplan, M. J. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0375-7 · Cited by 342
Aringer, M., Graninger, W. B., Steiner, G., & Smolen, J. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20576 · Cited by 342
Self-citationSeillet, C., Laffont, S., Trémollières, F., Rouquié, N., Ribot, C., Arnal, J.-F., Douin-Echinard, V., Gourdy, P., & Guéry, J.-C. (2012) · Blood · doi:10.1182/blood-2011-08-371831 · Cited by 332
Metadata
- Authors
- STUDNICKA-BENKE, A., STEINER, G., PETERA, P., & SMOLEN, J. S.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-11-01
- Volume
- 35
- Issue
- 11
- Pages
- 1067-1074
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2108529019
- Cited by
- 280
- References
- 40
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TUMOUR NECROSIS FACTOR ALPHA AND ITS SOLUBLE RECEPTORS PARALLEL CLINICAL DISEASE AND AUTOIMMUNE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. https://app.cochat.ai/papers/10.1093/rheumatology/35.11.1067
- The paper
- STUDNICKA-BENKE, A., STEINER, G., PETERA, P., & SMOLEN, J. S. (1996). TUMOUR NECROSIS FACTOR ALPHA AND ITS SOLUBLE RECEPTORS PARALLEL CLINICAL DISEASE AND AUTOIMMUNE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatology. https://doi.org/10.1093/rheumatology/35.11.1067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.